Home/Filings/4/0001615219-22-000067
4//SEC Filing

Rosenblum Mark J 4

Accession 0001615219-22-000067

CIK 0001615219other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 4:03 PM ET

Size

4.9 KB

Accession

0001615219-22-000067

Insider Transaction Report

Form 4
Period: 2022-05-03
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
  • Award

    Common Stock

    2022-05-03$0.19/sh+10,000$1,863120,319 total
Footnotes (1)
  • [F1]The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan.

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001329154

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:03 PM ET
Size
4.9 KB